Literature DB >> 12755648

The economic burden of depression with painful symptoms.

Paul E Greenberg1, Stephanie A Leong, Howard G Birnbaum, Rebecca L Robinson.   

Abstract

The economic burden of depression is substantial. The condition is highly prevalent, with both psychiatric and physical symptoms that often inflict pain. The chronic and often debilitating nature of depression results in costly medical therapies, as well as impaired workplace productivity. As a result, the overall economic burden of depression is comparable to that of serious physical illnesses, such as cancer and heart disease. This article presents an overview of the economic burden of depression and provides background on the relationship between depression and pain in this context. Research findings are also presented on the economic burden associated with a particular manifestation of pain among depressed patients, fibromyalgia. When painful physical symptoms accompany the already debilitating psychiatric and behavioral symptoms of depression, the economic burden that ensues for patients and their employers increases considerably. On purely economic grounds, more aggressive outreach may be warranted for patients with depression and comorbid pain to initiate treatment before symptoms are allowed to persist. However, more research is needed to assess the comprehensive economic impact that depression with painful physical symptoms can have on society.

Entities:  

Mesh:

Year:  2003        PMID: 12755648

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  28 in total

1.  [Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].

Authors:  C Ahrens; M Schiltenwolf; H Wang
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

2.  Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.

Authors:  Stuart J Eisendrath; Erin P Gillung; Kevin L Delucchi; Maggie Chartier; Daniel H Mathalon; Jude C Sullivan; Zindel V Segal; Mitchell D Feldman
Journal:  BMC Complement Altern Med       Date:  2014-03-11       Impact factor: 3.659

3.  The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.

Authors:  Bethany D Nugent; Susan M Sereika; Margaret Rosenzweig; Michael McCue; John D Merriman; Catherine M Bender
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

4.  Prevalence rates for depression by industry: a claims database analysis.

Authors:  Lawson Wulsin; Toni Alterman; P Timothy Bushnell; Jia Li; Rui Shen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-08       Impact factor: 4.328

5.  The importance of somatic symptoms in depression in primary care.

Authors:  André Tylee; Paul Gandhi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

6.  Effect of depression treatment on chronic pain outcomes.

Authors:  Carrie Farmer Teh; Alan M Zaslavsky; Charles F Reynolds; Paul D Cleary
Journal:  Psychosom Med       Date:  2009-10-29       Impact factor: 4.312

7.  Work performance of employees with depression: the impact of work stressors.

Authors:  Debra Lerner; David A Adler; William H Rogers; Hong Chang; Leueen Lapitsky; Thomas McLaughlin; John Reed
Journal:  Am J Health Promot       Date:  2010 Jan-Feb

8.  Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.

Authors:  Tsvetan Serchov; Hans-Willi Clement; Martin K Schwarz; Felice Iasevoli; Dilip K Tosh; Marco Idzko; Kenneth A Jacobson; Andrea de Bartolomeis; Claus Normann; Knut Biber; Dietrich van Calker
Journal:  Neuron       Date:  2015-08-05       Impact factor: 17.173

9.  Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs.

Authors:  Silvia L Cruz; Paulina Soberanes-Chávez; Nayeli Páez-Martinez; Carolina López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  2009-01-17       Impact factor: 4.530

10.  Temporomandibular pain and depression in adolescents--a case-control study.

Authors:  C Hirsch; J C Türp
Journal:  Clin Oral Investig       Date:  2009-04-01       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.